Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515 |
filingDate |
1976-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1977-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb2401e4ee9549c8f517a75a62906848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b266b8b4e6dbe9870e0c366bb3489af9 |
publicationDate |
1977-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4057633-A |
titleOfInvention |
Compositions and method of using quinolylaminobenzoylpiperazino-1-oxides |
abstract |
Novel compounds of the formula: <IMAGE> are disclosed with the corresponding hydrates and pharamceutically acceptable acid addition salts thereof, wherein R1 is halogen, lower alkyl, or trifluoromethyl; R2 is lower alkyl, substituted or unsubstituted phenyl or benzyl and R3 is hydrogen. The novel compounds are useful for the treatment of hypertension and anxiety in mammals, including humans. |
priorityDate |
1974-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |